Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILPS vs. Insulin Glargine in Type 2 Diabetes
NCT00666718Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2008
- Primary completion
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
Phase 3, randomised, open-label trial of insulin lispro protamine in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Apr 2008; status: completed.
02
Drugs
insulin lispro protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00666718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666718.